ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print March 29, 2006
Eur Respir J 2006, doi:10.1183/09031936.06.00076705
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
28/2/364    most recent
09031936.06.00076705v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cha, S-I.
Right arrow Articles by Brown, K.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cha, S-I.
Right arrow Articles by Brown, K.K.


ORIGINAL ARTICLE

Lymphoid interstitial pneumonia: clinical features, associations, and prognosis

S-I. Cha 1, M.B. Fessler , C.D. Cool , M.I. Schwarz , K.K. Brown *

1 Kyungpook National University Hospital, Korea

* To whom correspondence should be addressed. E-mail: brownk{at}njc.org.


   Abstract

Lymphoid interstitial pneumonia (LIP) is rare, and its clinical course incompletely described. The aim of this study was to examine the clinical features, associations, and prognosis of surgical lung biopsy-proven LIP.

The study group consisted of 15 subjects encountered over a 14-year period.

The majority of subjects were women (n=11), and the mean age was 47 years (17 to 78 years). Underlying systemic immune disorders were frequent, including Sjögren's syndrome (n=8), rheumatoid arthritis, systemic lupus erythematosus, polymyositis, common variable immunodeficiency, and dysproteinemia. Only three patients were classified as "idiopathic". Presenting symptoms were dominated by dyspnoea and cough. Restrictive physiology, a reduced diffusing capacity (62.5±18.4% predicted), and bronchoalveolar lavage lymphocytosis (30.5±29.1%) were noted. Thirteen patients received corticosteroid therapy. Of the nine whose response could be assessed, four clinically improved and four were stable. Overall median survival was 11.5 years. Of the seven patients who died, the primary cause of death was respiratory in three. Conversion to lymphoma was not identified.

In conclusion, histopathologic LIP is commonly associated with immune system dysregulation, with idiopathic LIP being extremely rare. Clinical stability or improvement with corticosteroids can be expected, however survival remains impaired.

Keywords:  Corticosteroid, lymphoid interstitial pneumonia, survival




This article has been cited by other articles:


Home page
ACCP Pulmonary Med Brd RevHome page
H. D. Tazelaar
Pathology of Diffuse and Neoplastic Disease
ACCP Pulmonary Med Brd Rev, January 1, 2009; 25(0): 501 - 512.
[Full Text] [PDF]


Home page
ChestHome page
E. Balestro, R. Polverosi, R. Vassallo, U. Pastore, F. Dal Farra, G. Rossi, and S. Calabro
A 40-Year-Old Man With Hemolytic Anemia, Ig Deficiency, and Bilateral Pulmonary Infiltrates
Chest, June 1, 2008; 133(6): 1517 - 1523.
[Full Text] [PDF]


Home page
ThoraxHome page
M A Valdivia-Arenas and N Sood
Lymphocytic interstitial pneumonia and pulmonary embolism in a patient with tetralogy of Fallot and common variable immunodeficiency: is there any link?
Thorax, May 1, 2008; 63(5): 470 - 471.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the European Respiratory Society.